ストックスクリーナーアプリを入手
19.18
2.46%
0.46
アフターアワーズ：
19.00
-0.18
-0.94%
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Amphastar Pharmaceuticals Inc (AMPH) Cash Flow - TradingKey
Rice Hall James & Associates LLC Increases Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Amphastar Pharmaceuticals Inc - TradingKey
AMPH|Amphastar Pharmaceuticals Inc|Price:18.720|Chg%:-0.150 - TradingKey
Amphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Epoch Investment Partners Inc. - MarketBeat
Amphastar Pharmaceuticals Inc (AMPH) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history - Yahoo Finance Australia
Amphastar Pharmaceuticals Inc (AMPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AMPH5896384 Bond Profile — Key Metrics - TradingView
AMPH5896384 Bond Coupon Profile — Rate & Payments - TradingView
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Quantedge Capital Pte Ltd Sells 78,200 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
US3209RAB9 Bond Coupon Profile — Rate & Payments - TradingView
US3209RAB9 Bond Profile — Key Metrics - TradingView
Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook and Growth Potential with 12% Upside - DirectorsTalk Interviews
Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal - ChartMill
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Crosses Below 50 Day Moving AverageShould You Sell? - MarketBeat
Dimensional Fund Advisors stake in Amphastar Pharmaceuticals (AMPH) hits 5.2% - Stock Titan
Form 4 Amphastar P For: 13 July By Investing.com - Investing.com Canada
Amphastar (AMPH) director awarded 7,886 RSUs and 16,646 options at $19.02 - Stock Titan
Amphastar Pharmaceuticals (AMPH) director reports initial insider ownership - Stock Titan
Amphastar (NASDAQ: AMPH) boosts board to 11, appoints Anthony Pierce - Stock Titan
Enterprise value to EBITDA forward of Amphastar Pharmaceuticals, Inc. – DUS:29A - TradingView
Amphastar unit gets FDA warning letter over manufacturing violations - MSN
Amphastar Pharmaceuticals, Inc. Files Form 8-K With SEC – Key Company Details, Contact Info, and Stock Listing on NASDAQ – Minichart - Minichart
Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility - marketscreener.com
Amphastar stock slips on FDA warning letter (AMPH:NASDAQ) - Seeking Alpha
Amphastar Pharmaceuticals subsidiary receives FDA warning letter over CGMP issues at California facility - TradingView
FDA Warning Letter targets Amphastar (NASDAQ: AMPH) IMS manufacturing facility - Stock Titan
Price to earnings forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals Inc. (AMPH) Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesForward EPS Estimate - dars.gov.et
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Crude Oil Gains 2%; Comcast Shares Spike Higher - Sahm
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Enterprise value to EBIT forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Amphastar Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $22, Implies 1% Upside - TradingView
AMPH Downgraded by B of A Securities -- Price Target Lowered to $20 - GuruFocus
BofA cuts Amphastar stock rating on limited growth visibility By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth Benchmark - marketscreener.com
BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20 - Moomoo
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – LS:A11664 - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth-Defensive Index - marketscreener.com
Amphastar Pharmaceuticals, Inc.(NasdaqGS: AMPH) added to Russell 2000 Dynamic Index - marketscreener.com
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – GETTEX:29A - TradingView
Price to book forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Price to sales forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Price to earnings forward of Amphastar Pharmaceuticals, Inc. – LS:A11664 - TradingView
Amphastar Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:AMPH) - TradingView
AMPH Forecast — Price Target — Prediction for 2027 - TradingView
Amphastar Pharmaceuticals Inc (AMPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price-Driven Insight from (AMPH) for Rule-Based Strategy - Stock Traders Daily
Over-the-Counter Rextovy Cleared for Opioid Overdose Treatment - Clinical Pain Advisor
Amphastar Pharmaceuticals Inc (AMPH) Institutional Confidence - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AMPH Technical Analysis & Stock Price Forecast - Intellectia AI
Amphastar Pharmaceuticals (AMPH) Drops Over 3%: Navigating Key Support Near $17.87Spring Pattern - dars.gov.et
Amphastar Pharmaceuticals Inc (AMPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):